(Q44343595)

2 December 2017

title

The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function (English)

1 reference

2 December 2017

1 reference

1 reference

1 reference

Andrej Skerjanec

1

1 reference

2 December 2017

James Berenson

2

1 reference

2 December 2017

ChyiHung Hsu

3

1 reference

2 December 2017

Pierre Major

4

1 reference

2 December 2017

Wilson H Miller

5

1 reference

2 December 2017

Christina Ravera

6

1 reference

2 December 2017

Horst Schran

7

1 reference

2 December 2017

John Seaman

8

1 reference

2 December 2017

Felix Waldmeier

9

1 reference

2 December 2017

publication date

1 February 2003

1 reference

The Journal of Clinical Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

43

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

154-162

1 reference

Bisphosphonates in the prevention of bone metastases: current evidence

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Bisphosphonates and the prevention of metastasis: first evidences from preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Chemical and biological prerequisites for novel bisphosphonate molecules: results of comparative preclinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Zoledronic acid in cancer patients with bone metastases: results of Phase I and II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Effect of renal function on risedronate pharmacokinetics after a single oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Bisphosphonates: a review of their pharmacokinetic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Adverse effects of bisphosphonates. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

The effect of dosing regimen on the pharmacokinetics of risedronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270002239824

21 January 2018

Identifiers

DOI

10.1177/0091270002239824

1 reference

2 December 2017

1 reference